Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy

Overview

The objective of this is to compare surgical outcomes of anterior colporrhaphy using nonabsorbable sutures with anterior colporrhaphy using absorbable sutures.

Full Title of Study: “Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy: a Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: June 30, 2023

Detailed Description

This trial is a prospective, randomized trial conducted with the aim to determine superiority of anterior colporrhaphy using nonabsorbable sutures over absorbable sutures with regard to the primary outcome. Participants will undergo reconstructive surgery for prolapse, including anterior colporrhaphy using the assigned suture materials under general or spinal anesthesia. The anterior colporrhaphy will be performed in a traditional manner with midline plication of the fibromuscular layer using either 2-0 nonabsorbable (polyester or polypropylene; Ethicon, Somerville, NJ) or absorbable (polyglactin 910 or polydioxanone; Ethicon) sutures. Concomitant procedures will be performed as intended prior to surgery. Women with a uterus in situ will undergo hysterectomy and all women will receive an apical suspension procedure, including uterosacral ligament suspension, sacrospinous ligament fixation, and iliococcygeal suspension, according to the preference of surgeon. Posterior colporrhaphy and incontinence surgery will also be performed, if indicated (i.e. women with Bp ≥-1 or documented urodynamic stress incontinence). Enrollment, treatment and data collection will be standardized by all sites. The study will be a single-blind study, as it is impossible to blind the study surgeon for the surgical procedure to which the subject in assigned. However, all outcomes assessors and the subjects will be blinded to the treatment assignment. Postoperative follow-up will take place after 5 weeks, 6 months and 12 months. Patients will undergo a standard gynecological examination including POPQ and fill in questionnaires.

Interventions

  • Device: Polyglactin 910 or polydioxanone
    • Vicryl or PDS II
  • Device: Polyester or polypropylene
    • Ethibond Excel or prolene

Arms, Groups and Cohorts

  • Active Comparator: Absorbable suture
    • will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyglactin 910 [Vicryl] or polydioxanone [PDS II] sutures.
  • Experimental: Nonabsorbable suture
    • will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyester [Ethibond Excel] or polypropylene [Prolene] sutures.

Clinical Trial Outcome Measures

Primary Measures

  • Surgical success
    • Time Frame: One year after surgery
    • defined as the absence of all of the following: (1) anterior vaginal descent beyond the hymen (POPQ point Ba>0); (2) presence of vaginal bulge symptoms (affirmative response to the question 3 from the Pelvic Floor Distress Inventory-20 (“do you usually have a bulge or something falling out that you can see or feel in your vaginal area?”; (3) re-treatment for recurrent anterior vaginal wall prolapse by either surgery or pessary.

Secondary Measures

  • The rate of anterior vaginal descent beyond the hymen
    • Time Frame: One year after surgery
    • POPQ point Ba>0
  • The rate of vaginal bulge symptoms
    • Time Frame: One year after surgery
    • an affirmative response to the question 3 from PFDI-20
  • The rate of re-treatment for recurrent anterior vaginal wall prolapse
    • Time Frame: One year after surgery
    • by either surgery or pessary
  • The rate of suboptimal anatomical outcome in each compartment
    • Time Frame: One year after surgery
    • POPQ point Ba, C, or Bp ≥-1
  • Change of POPQ values
    • Time Frame: From baseline to 1 year after surgery
    • point Ba, C, Bp and TVL
  • Change of PFDI-20 scores
    • Time Frame: From baseline to 1 year after surgery
    • The PFDI-20 is a valid and reliable condition-specific quality-of-life questionnaires for women with pelvic floor disorders. It has 20 items and 3 scales (Pelvic Organ Prolapse Distress Inventory, Colorectal-Anal Distress Inventory and Urinary Distress Inventory). Each scale is scored from 0 to 100; higher scores indicate greater symptom burden. The PFDI-20 total score is obtained by adding the scores from the 3 scale scores together (0-300).
  • The rate of adverse events related with anterior colporrhaphy
    • Time Frame: From baseline to 1 year after surgery
    • intraoperative- bladder injury, ureteral obstruction, massive bleeding postoperative- hematoma, vesico-vaginal fistula, ureteral obstruction, urinary tract infection, incomplete bladder emptying, overactive bladder or stress incontinence symptoms, suture erosion, vaginal wound dehiscence, infection or granulation tissue, etc.

Participating in This Clinical Trial

Inclusion Criteria

  • Anterior vaginal descent beyond the hymen (i.e. POPQ Ba>0) – Vaginal bulge symptoms (i.e. an affirmative response to the question 3 from the PFDI-20) – Reconstructive surgery is planned Exclusion Criteria:

  • Recurrent anterior vaginal wall prolapse – Reconstructive surgery using mesh or obliterative surgery for prolapse is planned – Known pelvic malignancy – Systemic glucocorticoid or immunosuppressant treatment – Subject wishes to retain her uterus – Subject is unable and unwilling to participate in

Gender Eligibility: Female

Minimum Age: 30 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Seoul National University Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Myung Jae Jeon, Associate professor – Seoul National University Hospital
  • Overall Official(s)
    • Myung Jae Jeon, MD, PhD, Principal Investigator, Seoul National University Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.